Pgd2 receptor antagonists for the treatment of inflammatory...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/44 (2006.01) A61K 31/4709 (2006.01) A61P 29/00 (2006.01) C07D 401/10 (2006.01) C07D 401/12 (2006.01)

Patent

CA 2561564

Disclosed herein are compounds represented by Structural Formula: (I) and (I- A). Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply "CRTH2" for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.

La présente invention a trait à des composés de formule structurelle (I) et (I-A). L'invention a également trait à l'utilisation de tels composés pour l'inhibition de récepteur couplé à une protéine G désigné molécule homologue de récepteur à fonction chimioattractive exprimée sur le Th2, ou simplement CRTH2' pour le traitement de troubles inflammatoires. Les variables de la formule structurelle (I) et (I-A) sont tels que définis dans la description.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pgd2 receptor antagonists for the treatment of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pgd2 receptor antagonists for the treatment of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pgd2 receptor antagonists for the treatment of inflammatory... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1963978

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.